Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.89 +0.03 (+1.88%)
As of: Nov 11, 2026 · 1:46 PM EST

Lexicon Pharmaceuticals (LXRX) Return on Assets [ROA] (2009 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) posted Return on Assets [ROA] of -21.01% for Q2 2026, up 24.24 percentage points from -45.24% a year earlier but down 10.33 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For FY2025, Lexicon Pharmaceuticals' Return on Assets [ROA] came in at -20.24%, up 54.45 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of -1.39 percentage points (FY2020 to FY2025).
  • In prior years, Lexicon Pharmaceuticals' Return on Assets [ROA] was -74.69% in FY2024 (+6.38 pp), -81.07% in FY2023 (-18.54 pp), -62.52% in FY2022 (-11.01 pp) and -51.52% in FY2021 (-32.67 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -78.03% in Q2 2022 to a high of -10.68% in Q1 2026 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last five quarters, with an average year-over-year change of +18.59 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2026, with a gain of 48.87 percentage points; the weakest was Q2 2022, with a drop of 98.85 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -10.68% (Q1 2026), -25.02% (Q4 2025) and -30.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Lexicon Pharmaceuticals 831.26 Mn 190.55 Mn 11.17 Mn -25.48%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -25.48%
Jun 30, 2026 -23.63%
Mar 31, 2026 -11.57%
Dec 31, 2025 -25.80%
Sep 30, 2025 -31.93%
Jun 30, 2025 -46.04%
Mar 31, 2025 -59.46%
Dec 31, 2024 -64.67%
Sep 30, 2024 -62.19%
Jun 30, 2024 -51.15%
Mar 31, 2024 -59.84%
Dec 31, 2023 -69.84%
Sep 30, 2023 -53.09%
Jun 30, 2023 -54.51%
Mar 31, 2023 -61.92%
Dec 31, 2022 -53.04%
Sep 30, 2022 -57,742.70%
Jun 30, 2022 -70,639.94%
Mar 31, 2022 -64,275.89%
Dec 31, 2021 -56,759.98%
API Access

Lexicon Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=LXRX&period=max&api_key=YOUR_API_KEY